Q² Solutions offers a range of genomic services to support drug discovery, precision medicine and clinical development. There are several advantages to incorporating genomic testing into immuno-oncology clinical trials. Watch this video to see Victor Weigman, Q² Solutions Translational Genomics, discuss how incorporating genomic testing facilitates research and clinical trial design to realize genomics-based medicine. You’ll also learn how genomic testing expands insight into more treatment options based on a patient’s tumor classification.